Bluejay Diagnostics, Inc. Operating Lease Right-of-Use Assets
Bluejay Diagnostics, Inc. (BJDX) had Operating Lease Right-of-Use Assets of $69.29 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Operating Lease, Right-of-Use Asset $69.29K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $91.49K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $113.29K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $134.68K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $69.29K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $91.49K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $113.29K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $134.68K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $155.68K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $176.30K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $209.79K 10-K · filed 2026-03-06 |
| 2024-09-30 | $227.50K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $263.40K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $298.65K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $333.27K 10-K · filed 2025-03-31 |
| 2023-09-30 | $367.25K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $400.61K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $433.36K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $465.51K 10-K · filed 2024-03-28 |
| 2022-09-30 | $497.62K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $573.04K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $396.70K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |